Bağırsak Mikrobiyotası ve Gastrointestinal Kanserler

Yash Raj Rastogi, Adesh K. Saini,Vijay Kumar Thakur, and Reena V. Saini; New Insights into Molecular Links Between Microbiota and Gastrointestinal Cancers: A Literature Review;; Int J Mol Sci. 2020 May; 21(9): 3212. Doi:10.3390/ijms21093212

Daniela Elena Serban; Gastrointestinal cancers: Influence of Gut Microbiota, Probiotics and Prebiotics, Cancer Letters, Volume 345, Issue 2, 10 April 2014,258-270

Sender, R.; Fuchs, S.; Milo, R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016, 14, e1002533

Qin J., Li R., Raes J., et al. A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing. Nature. 2010;464(7285):59–65. doi: 10.1038/nature08821.

R.I. Mackie, A. Sghir, H.R. Gaskins. Developmental Microbial Ecology of the Neonatal Gastrointestinal Tract. Am. J. Clin. Nutr., 69 (5) (1999), pp. 1035S-1045S,

D.N. Frank, A.L. St Amand, R.A. Feldman, E.C. Boedeker, N. Harpaz, N.R. Pace Molecular-Phylogenetic Characterization of Microbial Community İmbalances in Human İnflammatory Bowel Diseases. Proc. Natl. Acad. Sci. U. S. A., 104 (34) (2007), pp. 13780-13785,

Sommer F., Anderson J.M., Bharti R., Raes J., Rosenstiel P. The Resilience of The İntestinal Microbiota İnfluences Health and Disease. Nat. Rev. Microbiol. 2017; 15:630–638.

Moschen A.R., Gerner R.R., Wang J., Klepsch V., Adolph T.E., Reider S.J., Hackl H., Pfister A., Schilling J., Moser P.L., et al. Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota Alterations. Cell Host Microbe. 2016; 19:455–469.

Ma C., Han M., Heinrich B., Fu Q., Zhang Q., Sandhu M., Agdashian D., Terabe M., Berzofsky J.A., Fako V., et al. Gut Microbiome – Mediated Bile Acid Metabolism Regulates Liver Cancer Via NKT Cells. Science. 2018;360: eaan5931.

Desai M.S., Seekatz A.M., Koropatkin N.M., Kamada N., Hickey C.A., Wolter M., Pudlo N.A., Kitamoto S., Terrapon N., Muller A., et al. A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility. Cell. 2016; 167:1339–1353.

Gallo, A., Passaro, G., Gasbarrini, A., Landolfi, R., and Montalto, M. (2016). Modulation of Microbiota as Treatment for İntestinal İnflammatory Disorders: An Uptodate. World J. Gastroenterology 22 (32), 7186–7202. Doi:10.3748/wjg.v22.i32.7186

Duygu Ağagündüz, Ermelinda Cocozza, Özge Cemali, Ayşe Derya Bayazıt, Maria Francesca Nani, Ida Cerqua, Floriana Morgillo, Suna Karadeniz Saygılı, Roberto Berni Canani, Paola Amero, Raffaele Capasso,Understanding The Role of The Gut Microbiome in Gastrointestinal Cancer: A review Gastrointestinal and Hepatic Pharmacology Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1130562

Robinson K.M., Crabtree J., Mattick J.S.A., Anderson K.E., Hotopp J.C.D. Distinguishing potential bacteria-tumor associations from contamination in a secondary data analysis of public cancer genome sequence data. Microbiome. 2017; 5:9. doi: 10.1186/s40168-016-0224-8.

Tohidpour A. CagA-mediated Pathogenesis of Helicobacter pylori. Microb. Pathog. 2016; 93:44–55.

Tomkovich S, Yang Y, Winglee K, Gauthier J, Mühlbauer M, Sun X, et al. Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis. Cancer Res. 2017; 77:2620–2632.

Mima, K., Sukawa, Y., Nishihara, R., Qian, Z. R., Yamauchi, M., Inamura, K., et al. (2015). Fusobacterium Nucleatum and T Cells in Colorectal Carcinoma. JAMA Oncol. 1 (5), 653–661. doi:10.1001/jamaoncol.2015.1377

Yu T., Guo F., Yu Y., Sun T., Ma D., Han J., Qian Y., Kryczek I., Sun D., Nagarsheth N., et al. Fusobacterium Nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell. 2017; 170:548–563. doi: 10.1016/j.cell.2017.07.008.

Bullman S., Pedamallu C.S., Sicinska E., Clancy T.E., Zhang X., Cai D., Neuberg D., Huang K., Guevara F., Nelson T., et al. Analysis of Fusobacterium Persistence and Antibiotic Response in Colorectal Cancer. Science. 2017; 1448:1443–1448.

B.S. Jang, J.H. Chang, E.K. Chie, K. Kim, J.W. Park, M.J. Kim, et al. Gut Microbiome Composition is Associated with A Pathologic Response After Preoperative Chemoradiation in Patients With Rectal Cancer Int. J. Radiat. Oncol. Biol. Phys., 107 (4) (2020), pp. 736-746

M. Cui, H. Xiao, Y. Li, L. Zhou, S. Zhao, D. Luo, et al. Faecal Microbiota Transplantation Protects Against Radiation-İnduced Toxicity EMBO Mol. Med., 9 (4) (2017), pp. 448-461

Z. Peng, S. Cheng, Y. Kou, Z. Wang, R. Jin, H. Hu, et al. The Gut Microbiome is Associated with Clinical Response to Anti-PD-1/PD-L1 İmmunotherapy in Gastrointestinal Cancer; Cancer Immunol. Res., 8 (10) (2020), pp. 1251-1261

Yash Raj Rastogi, Adesh K. Saini,Vijay Kumar Thakur, and Reena V. Saini; New Insights into Molecular Links Between Microbiota and Gastrointestinal Cancers: A Literature Review;; Int J Mol Sci. 2020 May; 21(9): 3212. Doi:10.3390/ijms21093212

Daniela Elena Serban; Gastrointestinal cancers: Influence of Gut Microbiota, Probiotics and Prebiotics, Cancer Letters, Volume 345, Issue 2, 10 April 2014,258-270

Sender, R.; Fuchs, S.; Milo, R. Revised Estimates for the Number of Human and Bacteria Cells in the Body. PLoS Biol. 2016, 14, e1002533

Qin J., Li R., Raes J., et al. A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing. Nature. 2010;464(7285):59–65. doi: 10.1038/nature08821.

R.I. Mackie, A. Sghir, H.R. Gaskins. Developmental Microbial Ecology of the Neonatal Gastrointestinal Tract. Am. J. Clin. Nutr., 69 (5) (1999), pp. 1035S-1045S,

D.N. Frank, A.L. St Amand, R.A. Feldman, E.C. Boedeker, N. Harpaz, N.R. Pace Molecular-Phylogenetic Characterization of Microbial Community İmbalances in Human İnflammatory Bowel Diseases. Proc. Natl. Acad. Sci. U. S. A., 104 (34) (2007), pp. 13780-13785,

Sommer F., Anderson J.M., Bharti R., Raes J., Rosenstiel P. The Resilience of The İntestinal Microbiota İnfluences Health and Disease. Nat. Rev. Microbiol. 2017; 15:630–638.

Moschen A.R., Gerner R.R., Wang J., Klepsch V., Adolph T.E., Reider S.J., Hackl H., Pfister A., Schilling J., Moser P.L., et al. Lipocalin 2 Protects from Inflammation and Tumorigenesis Associated with Gut Microbiota Alterations. Cell Host Microbe. 2016; 19:455–469.

Ma C., Han M., Heinrich B., Fu Q., Zhang Q., Sandhu M., Agdashian D., Terabe M., Berzofsky J.A., Fako V., et al. Gut Microbiome – Mediated Bile Acid Metabolism Regulates Liver Cancer Via NKT Cells. Science. 2018;360: eaan5931.

Desai M.S., Seekatz A.M., Koropatkin N.M., Kamada N., Hickey C.A., Wolter M., Pudlo N.A., Kitamoto S., Terrapon N., Muller A., et al. A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility. Cell. 2016; 167:1339–1353.

Gallo, A., Passaro, G., Gasbarrini, A., Landolfi, R., and Montalto, M. (2016). Modulation of Microbiota as Treatment for İntestinal İnflammatory Disorders: An Uptodate. World J. Gastroenterology 22 (32), 7186–7202. Doi:10.3748/wjg.v22.i32.7186

Duygu Ağagündüz, Ermelinda Cocozza, Özge Cemali, Ayşe Derya Bayazıt, Maria Francesca Nani, Ida Cerqua, Floriana Morgillo, Suna Karadeniz Saygılı, Roberto Berni Canani, Paola Amero, Raffaele Capasso,Understanding The Role of The Gut Microbiome in Gastrointestinal Cancer: A review Gastrointestinal and Hepatic Pharmacology Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1130562

Robinson K.M., Crabtree J., Mattick J.S.A., Anderson K.E., Hotopp J.C.D. Distinguishing potential bacteria-tumor associations from contamination in a secondary data analysis of public cancer genome sequence data. Microbiome. 2017; 5:9. doi: 10.1186/s40168-016-0224-8.

Tohidpour A. CagA-mediated Pathogenesis of Helicobacter pylori. Microb. Pathog. 2016; 93:44–55.

Tomkovich S, Yang Y, Winglee K, Gauthier J, Mühlbauer M, Sun X, et al. Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis. Cancer Res. 2017; 77:2620–2632.

Mima, K., Sukawa, Y., Nishihara, R., Qian, Z. R., Yamauchi, M., Inamura, K., et al. (2015). Fusobacterium Nucleatum and T Cells in Colorectal Carcinoma. JAMA Oncol. 1 (5), 653–661. doi:10.1001/jamaoncol.2015.1377

Yu T., Guo F., Yu Y., Sun T., Ma D., Han J., Qian Y., Kryczek I., Sun D., Nagarsheth N., et al. Fusobacterium Nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy. Cell. 2017; 170:548–563. doi: 10.1016/j.cell.2017.07.008.

Bullman S., Pedamallu C.S., Sicinska E., Clancy T.E., Zhang X., Cai D., Neuberg D., Huang K., Guevara F., Nelson T., et al. Analysis of Fusobacterium Persistence and Antibiotic Response in Colorectal Cancer. Science. 2017; 1448:1443–1448.

B.S. Jang, J.H. Chang, E.K. Chie, K. Kim, J.W. Park, M.J. Kim, et al. Gut Microbiome Composition is Associated with A Pathologic Response After Preoperative Chemoradiation in Patients With Rectal Cancer Int. J. Radiat. Oncol. Biol. Phys., 107 (4) (2020), pp. 736-746

M. Cui, H. Xiao, Y. Li, L. Zhou, S. Zhao, D. Luo, et al. Faecal Microbiota Transplantation Protects Against Radiation-İnduced Toxicity EMBO Mol. Med., 9 (4) (2017), pp. 448-461

Z. Peng, S. Cheng, Y. Kou, Z. Wang, R. Jin, H. Hu, et al. The Gut Microbiome is Associated with Clinical Response to Anti-PD-1/PD-L1 İmmunotherapy in Gastrointestinal Cancer; Cancer Immunol. Res., 8 (10) (2020), pp. 1251-1261